keyboard_backspaceTerm

Details

  • menuadd_circle_outlineDomain IDclose
  • menuadd_circle_outlineConcept Class IDclose
  • menuadd_circle_outlineVocabulary ID
    help_outline
    close
  • menuadd_circle_outlineConcept IDclose
  • menuadd_circle_outlineConcept codeclose
  • menuadd_circle_outlineValidityclose
  • menuadd_circle_outlineConceptclose
  • menuadd_circle_outlineValid start08-Apr-2025close
  • menuadd_circle_outlineValid end08-Apr-2025close

Term connections

RelationshipRelates toConcept idVocabulary
Has Category
Medical conditions
35809577
UK Biobank
Has Value
acute myeloid leukaemia
35825400
UK Biobank
adrenal cancer
35825402
UK Biobank
anal cancer
35825456
UK Biobank
appendix cancer
35825490
UK Biobank
basal cell carcinoma
35825539
UK Biobank
bladder cancer
35825568
UK Biobank
bone metastases / bony secondaries
35825582
UK Biobank
brain cancer / primary malignant brain tumour
35825598
UK Biobank
breast cancer
35825603
UK Biobank
cancer of lip/mouth/pharynx/oral cavity
35825655
UK Biobank
cervical cancer
35825699
UK Biobank
chronic lymphocytic
35825733
UK Biobank
chronic myeloid
35825734
UK Biobank
cin/pre-cancer cells cervix
35825739
UK Biobank
colon cancer/sigmoid cancer
35825779
UK Biobank
ear cancer
35825907
UK Biobank
eye and/or adnexal cancer
35825981
UK Biobank
fallopian tube cancer
35826005
UK Biobank
female genital tract cancer
35826021
UK Biobank
gallbladder/bile duct cancer
35826101
UK Biobank
gum cancer
35826145
UK Biobank
heart / mediastinum cancer
35826171
UK Biobank
hodgkins lymphoma / hodgkins disease
35826200
UK Biobank
kaposis sarcoma
35826290
UK Biobank
kidney/renal cell cancer
35826296
UK Biobank
large bowel cancer/colorectal cancer
35826321
UK Biobank
larynx/throat cancer
35826324
UK Biobank
leukaemia
35826338
UK Biobank
lip cancer
35826351
UK Biobank
liver/hepatocellular cancer
35826357
UK Biobank
lung cancer
35826369
UK Biobank
lymphoma
35826375
UK Biobank
male genital tract cancer
35826395
UK Biobank
malignant insulinoma
35826406
UK Biobank
malignant lymph node, unspecified
35826407
UK Biobank
malignant melanoma
35826408
UK Biobank
meningeal cancer / malignant meningioma
35826443
UK Biobank
mesothelioma
35826450
UK Biobank
metastatic cancer (unknown primary)
35826456
UK Biobank
mouth cancer
35826491
UK Biobank
multiple myeloma
35826497
UK Biobank
myelofibrosis or myelodysplasia
35826511
UK Biobank
nasal cavity cancer
35826518
UK Biobank
non-hodgkins lymphoma
35826541
UK Biobank
non-melanoma skin cancer
35826543
UK Biobank
non-small cell lung cancer
35826544
UK Biobank
oesophageal cancer
35826563
UK Biobank
oropharynx / oropharyngeal cancer
35826581
UK Biobank
other cancer of urinary tract
35826607
UK Biobank
other haematological malignancy
35826619
UK Biobank
other salivary gland cancer
35826640
UK Biobank
ovarian cancer
35826670
UK Biobank
pancreas cancer
35826698
UK Biobank
parathyroid cancer
35826708
UK Biobank
parotid gland cancer
35826713
UK Biobank
penis cancer
35826722
UK Biobank
peripheral nerve/autonomic nerve cancer
35826733
UK Biobank
primary bone cancer
35826819
UK Biobank
prostate cancer
35826833
UK Biobank
rectal cancer
35826902
UK Biobank
respiratory / intrathoracic cancer
35826940
UK Biobank
retinoblastoma
35826951
UK Biobank
rodent ulcer
35826963
UK Biobank
salivary gland cancer
35827003
UK Biobank
sarcoma/fibrosarcoma
35827009
UK Biobank
sinus cancer
35827086
UK Biobank
skin cancer
35827089
UK Biobank
small cell lung cancer
35827097
UK Biobank
small intestine/small bowel cancer
35827098
UK Biobank
spinal cord or cranial nerve cancer
35827117
UK Biobank
squamous cell carcinoma
35827135
UK Biobank
stomach cancer
35827149
UK Biobank
testicular cancer
35827200
UK Biobank
thymus cancer / malignant thymoma
35827214
UK Biobank
thyroid cancer
35827147
UK Biobank
tongue cancer
35827231
UK Biobank
tonsil cancer
35827232
UK Biobank
trachea cancer
35827239
UK Biobank
uterine/endometrial cancer
35827311
UK Biobank
vaginal cancer
35827318
UK Biobank
vulval cancer
35827360
UK Biobank
Non-standard to Standard map (OMOP)
History of event
1340204
OMOP Extension
close modal

Athena – OHDSI Vocabularies Repository

@ 2015-2025, Odysseus Data Services, Inc. All rights reserved

Version 1.15.4.47.250313.1129

OMOP Vocabulary version: v20250227

Report application issue

Report vocabulary content issues

close modal

License Agreement

In order to use the SNOMED International SNOMED CT Browser and HemOnc, please accept the following license agreement:

SNOMED INTERNATIONAL SNOMED CT LICENSE AGREEMENT

SNOMED International SNOMED CT Browser includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the SNOMED International. All rights reserved. SNOMED CT® was originally created by the College of American Pathologists.
“SNOMED”, “SNOMED CT” and “SNOMED Clinical Terms” are registered trademarks of the SNOMED International (www.snomed.org)

Use of SNOMED CT in SNOMED International SNOMED CT Browser is governed by the conditions of the following SNOMED CT license issued by SNOMED International:
  1. The meaning of the terms “Affiliate”, or “Data Analysis System”, “Data Creation System”, “Derivative”, “End User”, “Extension”, “Member”, “Non-Member Territory”, “SNOMED CT” and “SNOMED CT Content” are as defined in the SNOMED International Affiliate License Agreement (see on the SNOMED International web site).
  2. Information about Affiliate Licensing is available athttp://www.snomed.org/snomed-ct/get-snomed-ct. Individuals or organizations wishing to register as SNOMED International Affiliates can register at mlds.ihtsdotools.org, subject to acceptance of the Affiliate License Agreement (see on the SNOMED International web site).
  3. The current list of SNOMED International Member Territories can be viewed at www.snomed.org/members. Countries not included in that list are "Non-Member Territories".
  4. End Users, that do not hold an SNOMED International Affiliate License, may access SNOMED CT® using SNOMED International SNOMED CT Browser subject to acceptance of and adherence to the following sub-license limitations:
    1. The sub-licensee is only permitted to access SNOMED CT® using this software (or service) for the purpose of exploring and evaluating the terminology.
    2. The sub-licensee is not permitted the use of this software as part of a system that constitutes a SNOMED CT "Data Creation System" or "Data Analysis System", as defined in the SNOMED International Affiliate License. This means that the sub-licensee must not use SNOMED International SNOMED CT Browser to add or copy SNOMED CT identifiers into any type of record system, database or document.
    3. The sub-licensee is not permitted to translate or modify SNOMED CT Content or Derivatives.
    4. The sub-licensee is not permitted to distribute or share SNOMED CT Content or Derivatives.
  5. SNOMED International Affiliates may use SNOMED International SNOMED CT Browser as part of a "Data Creation System" or "Data Analysis System" subject to the following conditions:
    1. The SNOMED International Affiliate, using SNOMED International SNOMED CT Browsermust accept full responsibility for any reporting and fees due for use or deployment of such a system in a Non-Member Territory.
    2. The SNOMED International Affiliate must not useSNOMED International SNOMED CT Browser to access or interact with SNOMED CT in any way that is not permitted by the Affiliate License Agreement.
    3. In the event of termination of the Affiliate License Agreement, the use ofSNOMED International SNOMED CT Browser will be subject to the End User limitations noted in 4.

HemOnc license agreement

The HemOnc Vocabulary is a derivative product of HemOnc.org, which is wholly owned and operated by HemOnc.org LLC. Use of the HemOnc Vocabulary is governed by the conditions of this License Agreement issued by HemOnc.org LLC:
  1. The meaning of the terms “Data Analysis System”, “Data Creation System”, and “License” is defined below.
  2. If you are already holding a HemOnc ontology License, you are subject to the terms and conditions of the License for the version of the HemOnc Vocabulary which was provided to you. If you wish to obtain this version of the HemOnc Vocabulary, you are subject to the following limitations.
  3. If you currently do not hold a HemOnc ontology License, you may access the HemOnc Vocabulary subject to acceptance of and adherence to the following limitations:
    1. You are permitted to access HemOnc using this software for the purpose of exploring and evaluating the terminology.
    2. You are permitted to use HemOnc as part of a system that constitutes a Data Analysis System, as defined below.
    3. You are not permitted the use of HemOnc as part of a system that constitutes a Data Creation System, as defined below. This means that you must not use HemOnc identifiers in any type of system intended for direct or indirect patient care.
    4. If you share the Licensed Material with a third party, attribution of the HemOnc vocabulary must be given to HemOnc.org LLC, with a URI or hyperlink to HemOnc.org provided if reasonably possible. Use of HemOnc by a third party would be limited to a Data Analysis System and a copy of this License Agreement must be supplied to the third party.
    5. You may not use HemOnc as a substitute for formal medical training, substitute it for independent clinical judgment, and construe it as offering medical advice.

If you wish to utilize the vocabulary for purposes other than specified here, contact us by emailing licensing@hemonc.org.

You agree to indemnify and hold HemOnc.org LLC and all parties who have contributed to HemOnc.org and this derivative product harmless from and against all claims, liability, losses, damages, costs, and expenses, including--but not limited to--legal fees

Definitions

Data Analysis System: a computer system that is used to analyze records or other data, but not if that system is also a Data Creation System

Data Creation System: a computer system that is used to create records or other data that is encoded using HemOnc, for the purposes of facilitating patient care

License: the separate CC BY-NC-SA 4.0 license to the full HemOnc ontology